Manuel, Iván <br/><br/>
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease.  [electronic resource] 

 -  Neuroscience  08 2016 
 - 284-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2016.05.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aging--drug effects<br/>Alzheimer Disease--metabolism<br/>Animals<br/>Autoradiography<br/>Brain--drug effects<br/>Carbachol--pharmacology<br/>Disease Models, Animal<br/>Disease Progression<br/>Galanin--pharmacology<br/>Humans<br/>Male<br/>Mice, Transgenic<br/>Neurotransmitter Agents--pharmacology<br/>Prodromal Symptoms<br/>Receptor, Cannabinoid, CB1--metabolism<br/>Receptor, Galanin, Type 1--metabolism<br/>Receptor, Muscarinic M2--metabolism<br/>Receptor, Muscarinic M4--metabolism<br/>Severity of Illness Index